Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation

被引:1
作者
Hagen, Julia M. [1 ]
Sutterland, Arjen L. [1 ]
Schirmbeck, Frederike [1 ,2 ]
Cohn, Danny M. [3 ]
Lok, Anja [1 ,4 ]
Tan, Hanno L. [4 ,5 ,6 ]
Zwinderman, Aeilko H. [7 ]
de Haan, Lieuwe [1 ,2 ,4 ]
机构
[1] Univ Amsterdam, Dept Psychiat, Amsterdam UMC, Amsterdam, Netherlands
[2] Arkin Mental Hlth Inst, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Vasc Med, Amsterdam UMC, Amsterdam, Netherlands
[4] Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[5] Univ Amsterdam, Heart Ctr, Dept Cardiol, Amsterdam UMC, Amsterdam, Netherlands
[6] Netherlands Heart Inst, Utrecht, Netherlands
[7] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam UMC, Amsterdam, Netherlands
关键词
Mood disorders; Anxiety disorders; Advanced glycation end products; Oxidative stress; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; RISK-FACTORS; DSM-IV; DEPRESSION; ANXIETY; ACCUMULATION; ASSOCIATION; MORTALITY;
D O I
10.1016/j.jad.2020.07.108
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Skin autofluorescence (SAF), indicating concentration of advanced glycation end products in the skin and oxidative stress, is cross-sectionally associated with affective disorders. Prospective studies of oxidative stress markers will help to clarify the pathophysiological role of oxidative stress. Methods: Data of a population-based cohort study were used. Presence of major depressive disorder, dysthymia, generalised anxiety disorder, panic disorder or social phobia was assessed at baseline and at 5-year follow-up with the Mini-International Neuropsychiatric Interview. Associations between SAF at baseline and incidence and persistence/recurrence of affective disorders were assessed with logistic regression. Results: Of 43,267 participants with no disorder at baseline, 2885 (6.7%) developed an incident disorder during follow-up. In 1360 of 3648 participants (37.3%) with an affective disorder at baseline, a persisting/recurrent disorder was present at follow-up. A modest association existed between SAF and incident affective disorders (OR=1.07 [95%CI 1.03-1.12], P<.001), specifically major depressive disorder (OR=1.11 [95%CI 1.04-1.19], P=.003); this association lost statistical significance after adjustment for sociodemographic factors. Associations between SAF and persistence/recurrence were not significant. Limitations: Many confounders might also act as intermediate: extensive adjustment for confounders caused overfitting and possibly masked effects of SAF on course of affective disorders. Relatively small sample sizes for analyses of SAF and persistence/recurrence of affective disorders resulted in a low power. Conclusions: Increased SAF modestly raises the odds of incident affective disorders, particularly major depressive disorder, providing evidence that oxidative stress plays a role in subsequent occurrence of affective disorders. However, significance of effects faded after adjustment for socioeconomic status.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 56 条
  • [1] Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
  • [2] Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia
    Arai, Makoto
    Yuzawa, Hiroko
    Nohara, Izumi
    Ohnishi, Tetsuo
    Obata, Nanako
    Iwayama, Yoshimi
    Haga, Seiichi
    Toyota, Tomoko
    Ujike, Hiroshi
    Arai, Mayumi
    Ichikawa, Tomoe
    Nishida, Atsushi
    Tanaka, Yoko
    Furukawa, Aizo
    Aikawa, Yuuzou
    Kuroda, Osamu
    Niizato, Kazuhiro
    Izawa, Ryosuke
    Nakamura, Kazuhiko
    Mori, Norio
    Matsuzawa, Daisuke
    Hashimoto, Kenji
    Iyo, Masaomi
    Sora, Ichiro
    Matsushita, Masaaki
    Okazaki, Yuji
    Yoshikawa, Takeo
    Miyata, Toshio
    Itokawa, Masanari
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2010, 67 (06) : 589 - 597
  • [3] Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
    Assies, J.
    Mocking, R. J. T.
    Lok, A.
    Ruhe, H. G.
    Pouwer, F.
    Schene, A. H.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2014, 130 (03) : 163 - 180
  • [4] Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders A Nationwide Study
    Benros, Michael E.
    Waltoft, Berit L.
    Nordentoft, Merete
    Ostergaard, Soren D.
    Eaton, William W.
    Krogh, Jesper
    Mortensen, Preben B.
    [J]. JAMA PSYCHIATRY, 2013, 70 (08) : 812 - 820
  • [5] Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study
    Black, C. N.
    Penninx, B. W. J. H.
    Bot, M.
    Odegaard, A. O.
    Gross, M. D.
    Matthews, K. A.
    Jacobs, D. R., Jr.
    [J]. TRANSLATIONAL PSYCHIATRY, 2016, 6 : e743 - e743
  • [6] Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study
    Blanc-Bisson, C.
    Velayoudom-Cephise, F. L.
    Cougnard-Gregoire, A.
    Helmer, C.
    Rajaobelina, K.
    Delcourt, C.
    Alexandre, L.
    Blanco, L.
    Mohammedi, K.
    Monlun, M.
    Rigalleau, V.
    [J]. CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [7] Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression (vol 22, pg 1701, 2017)
    Bouvier, E.
    Brouillard, F.
    Molet, J.
    Claverie, D.
    Cabungcal, J-H
    Cresto, N.
    Doligez, N.
    Rivat, C.
    Do, K. Q.
    Bernard, C.
    Benoliel, J-J
    Becker, C.
    [J]. MOLECULAR PSYCHIATRY, 2017, 22 (12) : 1795 - 1795
  • [8] Breheny P, 2009, STAT INTERFACE, V2, P369
  • [9] Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis
    Copeland, W. E.
    Shanahan, L.
    Worthman, C.
    Angold, A.
    Costello, E. J.
    [J]. PSYCHOLOGICAL MEDICINE, 2012, 42 (12) : 2641 - 2650
  • [10] Cumulative Depression Episodes Predict Later C-Reactive Protein Levels: A Prospective Analysis
    Copeland, William E.
    Shanahan, Lilly
    Worthman, Carol
    Angold, Adrian
    Costello, E. Jane
    [J]. BIOLOGICAL PSYCHIATRY, 2012, 71 (01) : 15 - 21